Evidence map›Paper›PMID 27418032›Full record

ArticleThe Journal of endocrinology2016

Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats.

Lesley A Hill, Tamara S Bodnar, Joanne Weinberg, Geoffrey L Hammond

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. RecombinantAnimals : an open access journal from MDPI · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lesley A HillDepartment of Cellular and Physiological SciencesUniversity of British Columbia, Vancouver, British Columbia, Canada Department of Obstetrics and GynaecologyUniversity of British Columbia, Vancouver, British Columbia, Canada.
Tamara S BodnarDepartment of Cellular and Physiological SciencesUniversity of British Columbia, Vancouver, British Columbia, Canada.
Joanne WeinbergDepartment of Cellular and Physiological SciencesUniversity of British Columbia, Vancouver, British Columbia, Canada.
Geoffrey L HammondDepartment of Cellular and Physiological SciencesUniversity of British Columbia, Vancouver, British Columbia, Canada Department of Obstetrics and GynaecologyUniversity of British Columbia, Vancouver, British Columbia, Canada Geoffrey.hammond@ubc.ca.
University of British Columbia · CADepartment of Physiological Sciences · RU

Funding

Alcohol and Stress: Interactive EffectsR37AA007789 · NIAAA · UNIVERSITY OF BRITISH COLUMBIA · PI WEINBERG, JOANNE · 2009 to 2018
$2.6M
Prenatal Alcohol and NeuroimmunityR01AA022460 · NIAAA · UNIVERSITY OF BRITISH COLUMBIA · PI BODNAR, TAMARA SONIA, RAINEKI, CHARLIS · 2013 to 2024
$2.3M
CIHR MOP-111102NIAAA NIH HHS R01 AA022460NIAAA NIH HHS R37 AA007789
6 · The paper itself

Abstract

Plasma corticosteroid-binding globulin (CBG) plays a critical role in regulating glucocorticoid bioavailability and is an acute phase 'negative' protein during inflammation. In an adjuvant-induced arthritis model, plasma CBG levels decrease in rats that develop severe inflammation, and we have now determined when and how these reductions in CBG occur. After administering complete Freund's adjuvant or saline intra-dermally at the tail base, blood samples were taken periodically for 16days. In adjuvant-treated rats, decreases in plasma CBG levels matched the severity of inflammation, and decreases were observed 4days before any clinical signs of inflammation. Decreases in CBG levels coincided with an ~5kDa reduction in its apparent size, consistent with proteolytic cleavage, and cleaved CBG lacked steroid-binding activity. At the termination of the experimental period, hepatic Cbg mRNA levels were decreased in rats with severe inflammation. While plasma TNF-α increased in all adjuvant-treated rats, increases in Il-4, IL-6, IL-10, IL-13 and IFN-γ were only observed in rats with cleaved CBG. Rats with cleaved CBG also exhibited increased spleen weights, and strong negative correlations were observed among CBG, IL-6 and spleen weights, respectively. However, there were no differences in hepatic Cbg mRNA levels in relation to the apparent proteolysis of CBG, suggesting that CBG cleavage occurs before changes in hepatic Cbg expression. Our results indicate that the levels and integrity of plasma CBG are biomarkers of the onset and severity of inflammation. Dynamic changes in the levels and function of CBG likely modulate the tissue availability of corticosterone during inflammation.

Indexed as

AnimalsBiomarkersBody WeightCytokinesFemaleInflammationLiverProteolysisRats, Sprague-DawleyTranscortinBiomarkersCytokinesTranscortincorticosteronecytokinesproteolysisserine protease inhibitorspleen weight

Identifiers

PMID27418032
PMCPMC5338597
OpenAlexW2468129987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.